Login to Your Account

Pharma: Clinic roundup

Friday, January 10, 2014

Avillion Group, of London, said it entered an exclusive collaborative development agreement with Pfizer Inc., of New York, to conduct a Phase III trial of Bosulif (bosutinib).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription